Silicon Laboratories, Inc. SLAB
221.24
(0.14)
(0.06%)
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 0.0×
Follow SLAB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
5.80 | 5.45 | 8.36 | 8.48 | |
P/FCF ratio |
70.35 | 65.01 | 389.69 | 0.00 | |
P/Operating CF |
125.45 | 512.17 | 1,390.61 | (500.10) | |
P/B ratio |
4.02 | 3.91 | 6.25 | 6.63 | |
Price to Tangible BV |
6.44 | 6.15 | 9.78 | 10.37 | |
EV/Sales |
5.98 | 5.62 | 8.53 | 8.69 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
45.56 | 46.05 | 133.24 | 224.66 | |
EV/FCF |
72.57 | 67.00 | 397.40 | (1,368.71) | |
Quick Ratio |
3.48 | 3.53 | 3.89 | 3.84 | |
Current Ratio |
4.49 | 4.69 | 5.11 | 5.41 | |
Net Debt/EBITDA |
110.31 | (88.90) | 50.21 | 176.71 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.59 | 0.63 | 0.66 | 0.69 | |
Operating CF/Net income |
(3.45) | (3.11) | (0.31) | 1.37 | |
Capex/Depreciation |
(0.76) | (1.21) | (1.18) | (1.46) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
42.57% | 43.00% | 41.50% | 41.64% | |
Selling, General and Administrative Expense of Revenue |
21.20% | 22.00% | 25.99% | 24.68% | |
Intangible Assets out of Total Assets |
0.32 | 0.31 | 0.31 | 0.32 | |
Share Based Compensation of Revenue |
9.73% | 9.93% | 9.86% | 11.24% | |
Graham Net Nets |
0.11 | 0.12 | 0.07 | 0.07 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.01%) | (1.52%) | (0.74%) | (0.54%) | |
Free Cash Flow Yield |
1.42% | 1.54% | 0.26% | (0.07%) | |
Revenue per Share |
6.27 | 6.36 | 6.48 | 6.87 | |
Operating CF per Share |
1.05 | 0.26 | 0.15 | (0.44) | |
Capex per Share |
(0.19) | (0.30) | (0.30) | (0.37) | |
Free Cash Flow per Share |
0.85 | (0.05) | (0.15) | (0.81) | |
Cash per Share |
13.37 | 13.56 | 13.31 | 11.96 | |
Shareholders Equity per Share |
32.61 | 33.45 | 33.33 | 32.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.61 | 33.45 | 33.33 | 32.97 | |
Free Cash Flow |
27.93 | (1.63) | (4.90) | (26.83) | |
Working Capital |
507.25 | 530.23 | 543.84 | 547.08 | |
Capital Expenditures |
(6.39) | (9.98) | (9.84) | (12.32) | |
Net Current Asset Value |
470.21 | 499.12 | 508.39 | 512.97 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.05 | 0.05 | 0.05 | |
Net Profit Margin |
(4.82%) | (1.29%) | (7.45%) | (4.64%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
58.09 | 59.50 | 64.59 | 68.15 | |
Average Payables |
50.15 | 46.58 | 55.10 | 55.28 | |
Average Inventory |
110.84 | 100.60 | 93.31 | 102.11 | |
Average Assets |
1,251.15 | 1,246.00 | 1,247.98 | 1,237.06 | |
Average Common Equity |
1,076.05 | 1,087.22 | 1,083.48 | 1,077.94 |
Columns are period end dates